Executive Director, Natixis Center for Investor Insight
Natixis Investment Managers – US Distribution
Dave Goodsell is executive director of the Natixis Center for Investor Insight, a research program dedicated to the analysis and reporting of issues and trends important to investors, their financial professionals, money managers, employers, governments and policymakers.
Goodsell leads global thought leadership initiatives for Natixis Investment Managers, one of the 20 largest asset managers in the world. In this role, he oversees a team of independent and affiliated researchers, analysts and writers who track major developments across the markets, economy and investing spectrum to understand attitudes and perceptions influencing the decisions of individual investors, financial professionals, consultants and institutional decision makers.
Under Goodsell’s leadership, the Center has conducted more than 60 research reports since 2010, with insights from more than 95,000 respondents in 30+ countries. Its findings are widely featured in major global financial publications, including The Wall Street Journal, Barron's, The Financial Times, and L'Agefie.
A veteran financial writer and frequent speaker, Goodsell joined Natixis as editorial director in 2001 after serving as editorial director at Liberty Funds (now Columbia Threadneedle) and Fidelity Investments. He regularly presents the Center’s findings to financial professionals, fund selectors and private bankers in the US, Europe and Asia, and also frequently serves as an expert panelist for industry organizations.
Fund selectors look to balance challenging markets and evolving client needs.
Institutional investors see a challenging year ahead. Read the full results from our 2023 Natixis Outlook Survey.
It’s the million dollar question: How much do I need to retire? See how a million in retirement savings isn’t what it used to be.
Retirement security is tough these days no matter where you call home. Natixis’ Center for Investor Insight head and an Australian retirement expert weigh in.